IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Bio Medica Laboratories
IPO is a SME Upcoming IPO coming on
NSE SME with an
IPO
size of
[●]
.
This IPO falls under the
Pharmaceutical sector, which has seen
40 IPOs
to date. Key sector metrics such as average PE ratio, IPO size, EBITDA margin,
and
PAT margin are compared below with the figures from the
Bio Medica Laboratories
IPO.
Bio Medica Laboratories IPO Peer Comparison with key metrics mentioned in the DRHP.
| Company Name | FV | CMP | EPS | PE | RoNW % | NAV | Revenue |
|---|---|---|---|---|---|---|---|
| Bio Medica Laboratories Limited | 10 | 10.67 | 99.59 | 16.05 | 979.49 | ||
| Zenotech Laboratories Limited | 10 | 62.41 | 0.92 | 67.84 | 6.01 | 15.76 | 561.29 |
| Shukra Pharmaceuticals Limited | 1 | 20.31 | 0.22 | 92.32 | 15.90 | 1.43 | 957.23 |
You can do performance analysis for Bio Medica IPO with Listed IPOs in the Pharmaceutical sector and review their IPO performance based on Merchant banker, Listing price, IPO Valuation and other metrics.
This IPO report captures the post-listing performance of IPOs in the Pharmaceutical sector, featuring key metrics like offer price, listing gain, and CMP to help investors assess return potential and sector sentiment.
Bio Medica Laboratories IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
The peers of
Bio Medica Laboratories ,
include other listed companies operating in the
(Pharmaceutical) segment. These peer companies
typically
offer similar services Some of the notable peers as per the DRHP of this
company
are
Bio Medica Laboratories Limited ,
Zenotech Laboratories Limited
Shukra Pharmaceuticals Limited
.
See the complete list of
current IPO
Peer Comparison is the method of evaluating an entity by comparing its performance, size of business form other entities operating in same industry or sector. It involves financial analysis bycomparing key financial metrics like Profitability, Net worth, Market Capitalization and Leverage. Peer comparison is beneficial for investors to make informed investment decisions and to identify any potential risks. IPO Performance tracker
Peer comparison helps to identify companies in the same sector with a similar business. It helps to compare the financial performance and valuation against its listed peers. An investor or an analyst can decide whether the IPO price is justified when compared to its peers. An investor can make informed decision whether to apply to IPO or not on basis of peer comparison. Know the process of DRHP and Peer companies Information required to be disclosed in DRHP.
As of now 40 SME IPOs are listed in this sector indicating strong growth in this sector. Choosing the best IPO depends on factors like, financial performance, valuation, market trends and future growth plans. IPO Review and performance.
A good PE Ratio for Pharmaceutical sector depends on various factors like, performance of the company, market conditions, company valuation and IPO Size. PE Ratio varies from sector to sector and company to company. Know the average PE Multiple in each sector.
Currently 40 companies are listed under Pharmaceutical sector. Based on the latest data from the Stock Exchanges. Choose the Best Merchant Banker from the Merchant Banker List
Performance of companies depends on various factors like, profits, future plans, Market share, PE Ratio etc. By assessing these factors investor can make better investment decisions.Bio Medica Laboratories Peer comparison provides IPO analysis of companies listed in this sector, on the basis of different Key performance indicators (KPI)like, Listing Gain of peers, current market price, PE Ratio and IPO Size.
Upcoming IPO refers to companies which have filed their DRHP with the Stock exchange and are awaiting approval from NSE Emerge or BSE SME. 13 companies have filed their DRHP for SME IPO under Pharmaceutical sector. .New IPO 2025-2026 and Upcoming IPO
PE Multiple is a metrics that is widely used for IPO Valuation. Merchant bankers in coordination with the company decides the PE Multiple.The PE Multiple depends on various factors and it should be analyzed in coordination with other financial metrics. Know the PE ratio of your company with PE Calculator provided by IPOplatform
Bio Medica Laboratories operates in Pharmaceutical and Manufacturing Of Pharmaceutical Parenteral Formulations. The Issue is listed on NSE SME in Aug, 2025. Bio Medica Laboratories IPO size was with Issue price of .
Merchant Banker(s) of Bio Medica Laboratories IPO: Narnolia Financial Services Limited
Bio Medica Laboratories IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Bio Medica Laboratories IPO listed at a listing price of against the offer price of .
The current market price of Bio Medica Laboratories is .
Why Us?
